Immediate Impact

55 standout
Sub-graph 1 of 24

Citing Papers

Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries
2024 Standout
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Standout
3 intermediate papers

Works of Andrew M. Ross being referenced

The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing.
2003
Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease
2002

Author Peers

Author Last Decade Papers Cites
Andrew M. Ross 66 16 6 88 55 13 320
H. Heatlie 16 21 1 74 167 13 344
Tapio Seiskari 80 57 7 61 65 16 352
Sarah Benge 50 13 61 26 9 293
Anna Vila‐Martí 67 4 8 62 45 28 356
C. Doherty 43 18 36 23 11 321
Julia Fashner 49 16 1 95 63 24 284
V. Ledoray 25 3 78 19 10 346
Christine Strunz‐Lehner 17 8 1 25 180 8 343
Ambarish J. Ambegaonkar 16 26 1 21 154 10 325
Olawale Salami 10 58 2 70 55 17 325

All Works

Loading papers...

Rankless by CCL
2026